\documentclass{article}%
\usepackage[T1]{fontenc}%
\usepackage[utf8]{inputenc}%
\usepackage{lmodern}%
\usepackage{textcomp}%
\usepackage{lastpage}%
\usepackage{graphicx}%
%
\title{Expression of Mina53, a novel c{-}Myc target gene, is a favorable prognostic marker in early stage lung cancer}%
\author{\textit{Greenwood Phoebe}}%
\date{06-01-2008}%
%
\begin{document}%
\normalsize%
\maketitle%
\section{Authors Dawn Buck and John Mantolo, commissioned by the National Cancer Institute, discussed their novel, entitled Mina53, the first novel to express a "high" expression of a gene "triggering cancer{-}predominantly among new{-}to{-}jazz{-}fatal cancer patients}%
\label{sec:AuthorsDawnBuckandJohnMantolo,commissionedbytheNationalCancerInstitute,discussedtheirnovel,entitledMina53,thefirstnoveltoexpressahighexpressionofagenetriggeringcancer{-}predominantlyamongnew{-}to{-}jazz{-}fatalcancerpatients}%
Authors Dawn Buck and John Mantolo, commissioned by the National Cancer Institute, discussed their novel, entitled Mina53, the first novel to express a "high" expression of a gene "triggering cancer{-}predominantly among new{-}to{-}jazz{-}fatal cancer patients."\newline%
The authors say that after carefully observing the initial seizure of Mina53, they found "more cancers now occurring more often because of direct contact" with the patient and their immune system.\newline%
"This is a novel diagnosis that we hope will trigger future trials of these types of novel immunotherapies for patients with the patient's best known genetic mutation," Annmarie Davidson, a Cancer Research UK executive director said.\newline%
The Mina53 mutation, or TGF15bN, affects 124,680 patients in the UK. Around 20,000 of them have "very{-}high" exposure to a high concentration of the TGF{-}15bN gene.\newline%
Mina53, which means "stomach{-}passing," is shown in the 2002{-}2006 print journal Clinical Cancer Research which "demonstrates significant reduction of cancer onset and mortality of new{-}to{-}jazz{-}favorable relatives of either cancer patient or relative.\newline%
The director of the National Institute for Cancer Research (NICR) European Molecular Biology Laboratory (EMBL) in Merondale, Switzerland, Dr. Lynn Johnson said the link between gene expression and cancer is "strong."\newline%
The authors show that Mina53 allows a non{-}hormonal form of testosterone to act to control the IgG gene, also known as the "hormonal gene," with reduction in levels of a DNA protein known as the Î±{-}synuclein. This difference plays a large role in how accurately the DNA is used for repair, can temporarily stop the mutation, and even more so when an increase in auto{-}targeting gene expression is due.\newline%
Since prenatal exposure to antigens are thought to increase the number of malignant tumor cells in the patients, the authors say high exposure to these gene genes also affects immunity. The severity of immune function for these diseases is estimated to increase by 25 percent.\newline%
Mina53 as written appears in the October 2007 issue of the journal Engineering \& Microbiology, The Physical Review \& Biophysics Journal.\newline%

%


\begin{figure}[h!]%
\centering%
\includegraphics[width=120px]{./photos_from_epoch_8/samples_8_264.png}%
\caption{a man in a suit and tie is smiling .}%
\end{figure}

%
\end{document}